Impact Factor 5.511
2017 JCR, Clarivate Analytics 2018

Among the world's top 10 most-cited Immunology journals

This article is part of the Research Topic

Non-Coding RNAs and Graft versus Host Disease

Editorial ARTICLE

Front. Immunol., 20 November 2018 |

Editorial: Non-coding RNAs and Graft versus Host Disease

  • 1Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States
  • 2Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert Ludwigs University of Freiburg, Freiburg, Germany

Editorial on the Research Topic
Non-coding RNAs and Graft versus Host Disease

Acute graft-vs.-host disease (GVHD) causes activation of multiple pro-inflammatory pathways in a diverse array of immune cell subsets that are often regulated by micro RNAs (miRs). MiRs are small non-coding RNAs that post-transcriptionally regulate gene expression and thereby impact inflammatory events at multiple levels including the release cytokines, chemokines, signaling by their receptors, cell-cycling, migration, and filament stabilization. Multiple inflammation-related miR-target genes are described, and while some miRs target anti-inflammatory genes other promote inflammation by targeting immunosuppressive genes. Additionally, the same miR can have different effects by preferentially targeting certain genes depending on the cell type and their context, in which the miR is analyzed. Through these diverse effects in various critical immune cell subsets miRs play critical functional role in GVHD and graft-vs.-leukemia effects (GVL). Thus, miRs are potentially attractive targets for the modification of allogeneic immune responses using miR mimics and inhibitors. Additionally, miR-levels in different body fluids could help to guide clinical decision making and function as biomarkers to predict or diagnose GVHD. This Research Topic, authored by experts in the field, describes the pleomorphic function of different miRs as potent regulators of multiple pro- or anti-inflammatory target genes, in various immune cell subsets that affect alloimmunity and GVHD. A better understanding of the miR-biology may help to mitigate GVHD and augment GVL effects and improve the outcomes after allogeneic hematopoietic transplantation.

Author Contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.


This work was supported by ERC (grant number 681012) to RZ (GVHDCure).

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: GvHD, micro RNA, Inflammation, non-coding RNAs, T cell

Citation: Reddy P and Zeiser R (2018) Editorial: Non-coding RNAs and Graft versus Host Disease. Front. Immunol. 9:2713. doi: 10.3389/fimmu.2018.02713

Received: 16 October 2018; Accepted: 05 November 2018;
Published: 20 November 2018.

Edited and reviewed by: Antoine Toubert, Paris Diderot University, France

Copyright © 2018 Reddy and Zeiser. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Robert Zeiser,